Shanghai Haohai Biological Tech Co (688366) - Total Liabilities
Based on the latest financial reports, Shanghai Haohai Biological Tech Co (688366) has total liabilities worth CN¥1.23 Billion CNY (≈ $180.52 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688366 cash flow metrics to assess how effectively this company generates cash.
Shanghai Haohai Biological Tech Co - Total Liabilities Trend (2012–2024)
This chart illustrates how Shanghai Haohai Biological Tech Co's total liabilities have evolved over time, based on quarterly financial data. Check 688366 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Shanghai Haohai Biological Tech Co Competitors by Total Liabilities
The table below lists competitors of Shanghai Haohai Biological Tech Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EUREKA FORBES LTD
NSE:EUREKAFORB
|
India | Rs22.66 Billion |
|
Tiangong International Company Limited
F:34T1
|
Germany | €5.96 Billion |
|
OceanFirst Financial Corp
NASDAQ:OCFC
|
USA | $12.90 Billion |
|
The Karnataka Bank Limited
NSE:KTKBANK
|
India | Rs1.06 Trillion |
|
Juewei Food Co Ltd
SHG:603517
|
China | CN¥2.04 Billion |
|
Nazara Technologies Limited
NSE:NAZARA
|
India | Rs7.88 Billion |
|
Teva Pharmaceutical Industries Ltd
TA:TEVA
|
Israel | ILA32.84 Billion |
|
Sivers IMA Holding AB
ST:SIVE
|
Sweden | Skr374.60 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Shanghai Haohai Biological Tech Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688366 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Haohai Biological Tech Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Haohai Biological Tech Co (2012–2024)
The table below shows the annual total liabilities of Shanghai Haohai Biological Tech Co from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.20 Billion ≈ $176.23 Million |
+10.67% |
| 2023-12-31 | CN¥1.09 Billion ≈ $159.24 Million |
+9.92% |
| 2022-12-31 | CN¥990.02 Million ≈ $144.87 Million |
+11.23% |
| 2021-12-31 | CN¥890.07 Million ≈ $130.25 Million |
+57.69% |
| 2020-12-31 | CN¥564.46 Million ≈ $82.60 Million |
+13.23% |
| 2019-12-31 | CN¥498.52 Million ≈ $72.95 Million |
-17.04% |
| 2018-12-31 | CN¥600.90 Million ≈ $87.93 Million |
-15.20% |
| 2017-12-31 | CN¥708.59 Million ≈ $103.69 Million |
+0.15% |
| 2016-12-31 | CN¥707.55 Million ≈ $103.54 Million |
+352.18% |
| 2015-12-31 | CN¥156.48 Million ≈ $22.90 Million |
-0.80% |
| 2014-12-31 | CN¥157.74 Million ≈ $23.08 Million |
+107.21% |
| 2013-12-31 | CN¥76.13 Million ≈ $11.14 Million |
+39.17% |
| 2012-12-31 | CN¥54.70 Million ≈ $8.00 Million |
-- |
About Shanghai Haohai Biological Tech Co
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyal… Read more